"Fortunate are those who take the first steps"? The psychosocial impact of novel drug development.
Clinical research
Clinical trials
Drug development
Psychosocial impact
Journal
Paediatric respiratory reviews
ISSN: 1526-0550
Titre abrégé: Paediatr Respir Rev
Pays: England
ID NLM: 100898941
Informations de publication
Date de publication:
Aug 2019
Aug 2019
Historique:
received:
20
02
2019
accepted:
20
02
2019
pubmed:
13
4
2019
medline:
27
2
2020
entrez:
13
4
2019
Statut:
ppublish
Résumé
Novel drug development offers people with cystic fibrosis exciting opportunities but is not without challenges. Currently, there is an understandable emphasis on protecting patients' physical health when developing treatments. However, there appears to be little consideration of how novel drug development impacts on psychosocial wellbeing, or the downstream consequences of this. Using an illustrative case and reviewing the literature we explore themes regarding the psychosocial impact of trial participation and novel drug development and identify areas requiring further research. Through this, we hope to prepare healthcare professionals to better understand the needs of their patients in this rapidly evolving landscape.
Identifiants
pubmed: 30975518
pii: S1526-0542(19)30019-3
doi: 10.1016/j.prrv.2019.02.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
9-11Informations de copyright
Copyright © 2019 Elsevier Ltd. All rights reserved.